nVerses Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
nVerses Capital's COLL Position: Q3 2026 in Review
nVerses Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2026, closing a stake of 5,574 shares — an estimated $202K sold.
nVerses Capital first reported a position in COLL in Q1 2024 and held it in 3 quarters. The position peaked at $202K in Q2 2026. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- nVerses Capital reported no remaining Collegium Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 5,574 Collegium Pharmaceutical shares in Q3 2026, an estimated $202K.
- nVerses Capital first reported a position in Collegium Pharmaceutical in Q1 2024 and held it in 3 quarters.
- nVerses Capital's Collegium Pharmaceutical position peaked at $202K in Q2 2026.
- 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.